Facioscapulohumeral muscular dystrophy is a disorder characterized by weakness and atrophy in the muscles of the face, upper arms, and shoulders. Like other forms of muscular dystrophy, individuals with facioscapulohumeral muscular dystrophy usually first exhibit symptoms during infancy or childhood, and the symptoms slowly worsen and spread to other parts of the body. Researchers know that a deletion in the D4Z4 gene on the end of chromosome 4 causes facioscapulohumeral muscular dystrophy, but they also suspect that there are other genetic factors that contribute. Facioscapulohumeral muscular dystrophy has no cure, but most individuals with the disorder have normal life spans.
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Muscular Dystrophy, Facioscapulohumeral below!
For more information on how to use Laverne, please read the How to Guide.
We have 889 products for the study of Muscular Dystrophy, Facioscapulohumeral that can be applied to Western Blot, Chromatin Immunoprecipitation, Immunocytochemistry/Immunofluorescence, Flow Cytometry, Immunohistochemistry from our catalog of antibodies and ELISA kits.
Muscular Dystrophy, Facioscapulohumeral is also known as Atrophy, Facioscapulohumeral, Dystrophy, Facioscapulohumeral Muscular, Facioscapulohumeral Muscular Dystrophies, Facioscapulohumeral Muscular Dystrophy, Fascioscapulohumeral Muscular Dystrophy.
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.